1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
(
- Contribution to journal › Article
- 2022
-
Mark
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
(
- Contribution to journal › Article
- 2021
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
- 2020
-
Mark
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis
(
- Contribution to journal › Article
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
(
- Contribution to journal › Article
- 2016
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
(
- Contribution to journal › Article